The expression of NF-κB in peripheral blood mononuclear cells of type 2 diabetes patients and its related factors

Xiao-hong L(U),Xiao-gang FENG,Lan HE,Bing-yin SHI,Huai-yu WANG,Dan PU,Yi-ning SUN,Wen-xu ZHOU
2011-01-01
Abstract:Objective: To investigate the changed expression of nuclear factor kappa B (NF-κB) in peripheral blood mononuclear cells (PBMCs) of type 2 diabetes patients without vascular complications and its relationship to oxidative stress and glucose metabolism. Methods: The study subjects comprised 30 diabetes patients with type 2 diabetes (T2DM) without vascular complications and 30 non-diabetic controls (NDM). The content of malondiadehyde (MDA) and the activity of superoxide dismutase (SOD) in plasma were detected by chemical colorimetric method. The protein levels of NFκB-p65 and inhibitor kappa B-α (IκB-α) in PBMCs in T2DM patients were measured by Western blot. Other laboratory data including glycosylated hemoglobin (GHb), total cholesterol and triglyceride were evaluated. Results The protein level of NF-κB/p65 was significantly increased in the T2DM patients. Compared to NDM controls, these patients also had significantly higher concentration of MDA and lower SOD activities. The protein level of NF-κB/p65 was positively associated with MDA concentration and GHb. However, there was no significant difference in IκB-α protein level between the T2DM patients and NDM controls. Conclusion: Type 2 diabetes patients without vascular complications have an increased NF-κB/p65 expression, which is associated with oxidative stress and the level of glucose control.
What problem does this paper attempt to address?